AstraZeneca’s antibody cocktail helps prevent COVID-19 for at least 6 months


Nov 18 (Reuters) – AstraZeneca (AZN.L) on Thursday cemented its lead in bringing a preventative COVID-19 shot to market, saying its antibody cocktail offered 83% protection over six months, providing another possible weapon in the fight against the pandemic.

The therapy, called AZD7442 or Evusheld, had previously been shown to confer 77% protection against symptomatic illness after three months, in an earlier readout of the late-stage PROVENT trial in August. read more


Reuters source: